Luqa Pharmaceuticals, a China specialty care company that markets solutions in dermatology and other specialty areas, has completed a $15 million round of fund raising. The new financing was led by Morningside Ventures. Proceeds will be used to expand, develop and fund on-going operations and commercialization of Luqa’s product range. Luqa has been able to record strong growth since the launch of its first product in 2013. Luqa has now launched an additional eight products, with three more la...